Related Experiment Video

Updated: Jun 28, 2026

Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants
08:22

Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants

Published on: December 22, 2023

Therapeutic drug monitoring for triazoles

William W Hope1, Eliane M Billaud, Jodie Lestner

  • 1School of Translational Medicine, The University of Manchester, Manchester, UK. william.hope@manchester.ac.uk

Current Opinion in Infectious Diseases
|November 4, 2008
PubMed
Abstract

Insights

Therapeutic drug monitoring of triazoles is crucial for improving outcomes in immunocompromised patients. Optimizing drug levels ensures effective treatment and minimizes toxicity for invasive fungal infections.

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Background:

  • Invasive fungal infections pose significant risks for immunocompromised individuals.
  • Triazoles are key antifungal agents, but require careful management.

Purpose of the Study:

  • To review the role of therapeutic drug monitoring in optimizing triazole therapy.
  • To highlight concentration-effect and toxicity relationships of triazoles.

Main Methods:

  • Review of current literature on triazole pharmacokinetics and pharmacodynamics.
  • Analysis of therapeutic drug monitoring applications for specific triazoles.

Main Results:

  • Triazoles demonstrate clear concentration-effect and concentration-toxicity relationships.
  • Understanding pharmacokinetics and pharmacodynamics aids in defining optimal drug exposure.
  • Therapeutic drug monitoring is applicable to fluconazole, itraconazole, voriconazole, and posaconazole.

Conclusions:

  • Therapeutic drug monitoring is essential for maximizing efficacy and safety of triazoles.
  • Optimized triazole therapy improves outcomes for immunocompromised patients with fungal infections.

More Related Videos

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...